Structure Therapeutics Company
Platform combining computational chemistry and biophysics for rational drug design against G-protein coupled receptors (GPCRs).
Headquarters:
USA / China
Founded Date:
2016
Industry:
Advanced BioTech R&D
Total Funding:
> $600 M